Concepedia

Publication | Open Access

Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)

53

Citations

17

References

2024

Year

References

YearCitations

Page 1